This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Prevalence and Impact of Relapse in Patients With Schizophrenia

John Lauriello, MD

Published: March 24, 2020


Many individuals with schizophrenia experience multiple relapses, which are associated with serious and potentially fatal outcomes. Nonadherence to antipsychotic medications is a major contributor to relapse. By using reliable strategies to measure adherence and identify patients who are not taking their medications as prescribed, clinicians can intervene to possibly prevent relapse or decrease its severity.

From the Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania

To cite: Lauriello J. Prevalence and impact of relapse in patients with schizophrenia. J Clin Psychiatry. 2020;81(1):MS19053BR1C.
To share:

© Copyright 2020 Physicians Postgraduate Press, Inc.

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Volume: 81

Quick Links: